Two distinct amphipathic peptide antibiotics with systemic efficacy

Proc Natl Acad Sci U S A. 2020 Aug 11;117(32):19446-19454. doi: 10.1073/pnas.2005540117. Epub 2020 Jul 28.

Abstract

Antimicrobial peptides are important candidates for developing new classes of antibiotics because of their potency against antibiotic-resistant pathogens. Current research focuses on topical applications and it is unclear how to design peptides with systemic efficacy. To address this problem, we designed two potent peptides by combining database-guided discovery with structure-based design. When bound to membranes, these two short peptides with an identical amino acid composition can adopt two distinct amphipathic structures: A classic horizontal helix (horine) and a novel vertical spiral structure (verine). Their horizontal and vertical orientations on membranes were determined by solid-state 15N NMR data. While horine was potent primarily against gram-positive pathogens, verine showed broad-spectrum antimicrobial activity. Both peptides protected greater than 80% mice from infection-caused deaths. Moreover, horine and verine also displayed significant systemic efficacy in different murine models comparable to conventional antibiotics. In addition, they could eliminate resistant pathogens and preformed biofilms. Significantly, the peptides showed no nephrotoxicity to mice after intraperitoneal or intravenous administration for 1 wk. Our study underscores the significance of horine and verine in fighting drug-resistant pathogens.

Keywords: NMR; antibiotic resistance; nephrotoxicity; peptide antibiotics; systemic efficacy.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Anti-Bacterial Agents / chemistry*
  • Anti-Bacterial Agents / metabolism
  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / therapeutic use
  • Antimicrobial Cationic Peptides / chemistry*
  • Antimicrobial Cationic Peptides / metabolism
  • Antimicrobial Cationic Peptides / pharmacology*
  • Antimicrobial Cationic Peptides / therapeutic use
  • Bacteria / drug effects
  • Bacteria / growth & development
  • Bacterial Infections / drug therapy
  • Biofilms / drug effects
  • Biofilms / growth & development
  • Cell Membrane / metabolism
  • Databases, Protein
  • Drug Design
  • Drug Resistance, Bacterial / drug effects
  • Humans
  • Hydrophobic and Hydrophilic Interactions
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Microbial Sensitivity Tests
  • Structure-Activity Relationship
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Antimicrobial Cationic Peptides